This is the authors' abstract. We don't add key points for this paper.
Evidence has accumulated indicating that the fibrinoid deposits found in histopathologic ma- terial in certain human diseases-for example, acute lupus erythematosus and polyarteritis-may be derived, at least in part, from fibrinogen, fibrin, or a closely related protein (1, 2). Studies of the conditions under which similar deposits are laid down in the blood vessels of rabbits during the generalized Shwartzman reaction (3, 4) and after injection of gram-negative bacterial endotoxin in combination with acidic polymers of large molecu- lar size (5, 6), have provided an experimental model for studying the origin of these deposits. In the rabbit a direct correlation between the dis- appearance of fibrinogen from the circulating blood and the appearance of fibrinoid within the glomerular blood vessels was observed, and the suggestion was made that endotoxin produced an increase in the in vivo precipitability of fibrinogen by acidic polymers (7, 8). It was shown that within less than one hour after an intravenous in- jection of endotoxin, a change in the stability of fibrinogen occurred which was manifested by the cold-insolubility of this protein in the presence of heparin (7, 9). It seemed possible that this heparin-precipitable form of fibrinogen might rep- resent, in the rabbit, a precursor of fibrinoid, and a study of the occurrence of a similar cold-insoluble, heparin-precipitable component in human plasma was therefore undertaken.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Smith et al. (1957) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: